Jeffrey Conroy serves as Chief Scientific Officer for OmniSeq. He oversees the scientific functions of OmniSeq, including Research and Development (R&D), Bioinformatics and Information Technology.
He leads business development activities with key industry and pharmaceutical partners, and oversees the development and implementation of advanced diagnostic tests from target design through analytical validation.
Prior to joining OmniSeq, Jeff spent three years as Director of Genomic Technologies in the Center for Personalized Medicine at Roswell Park Comprehensive Cancer Center.While at Roswell, he also served 15 years as Co-Director of the Genomics Shared Resource, overseeing its expansion to more than 50 genomics-based service offerings and a user base of 200+ investigators per year. During his clinical and basic research career, Jeff has authored or co-authored more than 70 peer-reviewed manuscripts with a focus on genomics and molecular pathology.